Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.
about
Update on the clinical use of buprenorphine: in opioid-related disordersUtilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependenceAwareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program.Consumer attitudes about opioid addiction treatment: a focus group study in New York City.Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participantsLong-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.Predictors of methadone treatment retention from a multi-site study: a survival analysis.Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.The nature of methadone diversion in England: a Merseyside case studyIllicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids.Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention.Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine.Prescription medication exchange patterns among methadone maintenance patients.Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.Buprenorphine Prescribing: To Expand or Not to ExpandPrior buprenorphine experience is associated with office-based buprenorphine treatment outcomes.Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.Illicit use of methadone and buprenorphine among adolescents and young adults in SwedenThe New Kid on the Block--Incorporating Buprenorphine into a Medical Toxicology Practice.Buprenorphine treatment for narcotic addiction: not without risks.Methadone-related deaths - epidemiological, pathohistological, and toxicological traits in 10-year retrospective study in Vojvodina, Serbia.Buprenorphine/Naloxone Maintenance Therapy: an Observational Retrospective Report on the Effect of Dose on 18 months Retention in an Office-Based Treatment Program.Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013.Methadone "callbacks" within a veterans affairs opioid treatment program: Detecting methadone misuse.Mise à jour sur l’utilisation clinique de la buprénorphine: pour les troubles reliés aux opioïdes.Increasing diversion of methadone in Vancouver, Canada, 2005-2015.Suboxone misuse along the opiate maintenance treatment pathway.
P2860
Q26829140-DF086326-A3EF-42F2-A9FD-B8E93A3701A3Q26865674-64A14A2F-6941-4EE0-A35C-57367FFED467Q33576948-E4C2B4E1-7B73-4C4E-902E-3ACA8C8E5505Q33576957-0624836B-FF12-43AB-A7B1-B7A2EA5B7064Q34432627-500F8301-9994-4463-BD80-D096DABE40ABQ34602727-085A1878-9010-47F7-A4E0-9BC656D15F97Q35109559-4B9E4154-182C-43E3-8B03-086C53803AF9Q35141390-ACD8AD5B-762E-4311-99CC-3EFF7DD2FEF9Q35167576-4D116FE2-C410-4DC1-9132-372F884D396DQ35774742-07DC7C63-1AB0-4383-A98B-8EA4F006FB52Q35800468-C0E67EDE-F72B-499D-9FDD-BCB7222E4710Q36030969-B052D554-A764-4B0B-B652-1F4F8593C8EEQ36253355-627F4A07-9DD4-40AB-A95D-5B8A99DBEC1EQ36438049-658686F1-C9B4-481E-AA1B-204234EEA6CCQ36750914-1E3DCEE7-0475-4415-A2EE-10548ACFB7CCQ36855631-7BA22087-469E-4534-9889-9BF5FE9F0F24Q37079839-558C6777-1ADD-4E86-92D4-27EE3DAAF399Q37248672-F91B43F7-CEB9-4C02-8071-68BEA9E00861Q37369585-0FC8C882-6A93-4FCC-8A11-E01487F1D296Q38634946-898D7B20-B2BB-4FED-B82F-85BFAAE412A7Q40283005-AC44F056-85E6-448C-AF8D-79442A384847Q42238738-F9861FF9-2357-4E8E-AD83-FFC927524982Q42375619-3A423218-B1B1-41B8-A6AD-DFE705076947Q43584958-AF068F27-0160-4824-835B-080FAD32297EQ44342184-5569A2F2-6A77-4BB0-83C5-5C25517A7DA4Q45847009-EAE742FC-4E49-40C7-9468-7618918C5132Q47226505-AFAEA40E-BD19-48E7-A42E-3CA895C8D246Q47777588-C097848D-CA4C-44E6-83D8-88E07DBA8D58
P2860
Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Uses of diverted methadone and ...... iduals in Baltimore, Maryland.
@en
Uses of diverted methadone and ...... iduals in Baltimore, Maryland.
@nl
type
label
Uses of diverted methadone and ...... iduals in Baltimore, Maryland.
@en
Uses of diverted methadone and ...... iduals in Baltimore, Maryland.
@nl
prefLabel
Uses of diverted methadone and ...... iduals in Baltimore, Maryland.
@en
Uses of diverted methadone and ...... iduals in Baltimore, Maryland.
@nl
P2093
P2860
P1476
Uses of diverted methadone and ...... iduals in Baltimore, Maryland.
@en
P2093
Adrienne Ruhf
Barry S Brown
Heather Schacht Reisinger
James A Peterson
Kevin E O'Grady
Michael H Agar
Robert P Schwartz
Shannon Gwin Mitchell
Sharon M Kelly
P2860
P304
P356
10.1080/10550490903077820
P577
2009-09-01T00:00:00Z